Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study

Table 4 Outcomes by PVL status

Management or Outcome	PVL positive (n = 141)	PVL negative (n = 148)	p-value
Initial antibiotics effective	75 (53.2)	90 (60.8)	0.191
Lincosamide/linezolid initial Tx^a	9 (6.4)	4 (2.8)	0.141
Lincosamide/linezolid 3d^b	29 (20.8)	10 (6.8)	<0.001
Surgery performed	103 (73.0)	66 (44.6)	<0.001
HDA/ICU admission^c	8 (5.7)	17 (11.5)	0.079
Median length of stay-days (range)	5.0 (0–81)	13.5 (0–638)	<0.001
Death within 30 days	4 (2.8)	10 (6.8)	0.121
Death within 1 year	9 (6.4)	29 (19.6)	0.001

^aLincosamide or linezolid prescribed in the initial therapy.
^bLincosamide or linezolid added to therapy within 3 days of isolate collection.
^cHigh dependency area or intensive care unit admission.
Number (%).

ISSN: 1471-2334